|1.||Zhu, Yubing: 1 article (04/2008)|
|2.||Li, Jian Hua: 1 article (04/2008)|
|3.||Di, Bin: 1 article (04/2008)|
|4.||Wu, Chun Yong: 1 article (04/2008)|
|5.||Fan, Hongwei: 1 article (04/2008)|
|6.||Hu, Qin: 1 article (04/2008)|
|7.||Xiao, DaWei: 1 article (04/2008)|
|8.||Zou, Jianjun: 1 article (04/2008)|
|9.||Wang, Guang Ji: 1 article (04/2008)|
|10.||Tamaya, Teruhiko: 1 article (08/2005)|
10/01/1986 - "[Epidemiological and therapeutic studies on gonorrheal infections--clinical efficacy of T-2588. "
10/01/1986 - "In conclusion, T-2588 can be to be expected sufficiently clinically effective against gonorrheal infections, including PPNG, at a daily dose of 600 mg t.i.d. "
08/01/1989 - "[Clinical studies of cefteram pivoxil in pediatric infection]."
08/01/1989 - "Cefteram pivoxil (CFTM-PI), in fine granules, was studied in pediatric infections and the results obtained are summarized below. "
08/01/1989 - "[Clinical evaluation of cefteram pivoxil fine granules in pediatric infections]."
|2.||Soft Tissue Infections
11/01/1989 - "[The studies on clinical efficacy of Tomiron in the surgical patients: skin and soft tissue infection]."
11/01/1989 - "These results indicate that Tomiron is a useful oral antimicrobial agent in the treatment and prophylaxis of surgical infection, mainly skin and soft tissue infection."
02/01/1990 - "The usefulness of cefteram pivoxil (CFTM-PI) was evaluated in 99 cases with respiratory tract infections: 32 cases with acute bronchitis, 51 cases with infectious exacerbations of chronic respiratory diseases and 16 cases with pneumonia. "
11/01/1986 - "T-2588 was used on 55 patients with respiratory tract infections and 44 cases were evaluated; 23 patients with pneumonia, 12 patients with acute bronchitis, 2 patients with chronic bronchitis, 1 patient with diffuse panbronchiolitis and 6 patients with bronchiectasis with infection. "
01/01/1998 - "The efficacy of CS-834, a novel oral carbapenem, was assessed by using a murine model of pneumonia caused by penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae and was compared with those of oral cephems, i.e., cefteram pivoxil, cefpodoxime proxetil, cefdinir, and cefditoren pivoxil. "
|4.||Respiratory Tract Infections (Respiratory Tract Infection)
11/01/2004 - "Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method."
01/01/1990 - "[Clinical studies on cefteram pivoxil in the treatment of respiratory infections]."
11/01/2004 - "In a double-blind study, the efficacy and safety of the novel cephem antibiotic cefcapene pivoxil (CFPN-PI; 450 mg/day) was compared with cefteram pivoxil (CFTM-PI; 600 mg/day) in 171 patients with chronic respiratory tract infections. "
02/01/1990 - "[Clinical evaluation of cefteram pivoxil in respiratory tract infections]."
01/01/1990 - "Cefteram pivoxil (CFTM-PI), a new ester type cephem antibiotic, was administered at a daily dose of 600 mg to 81 patients with respiratory infections. "
|3.||cefditoren pivoxil (Spectracef)
|4.||cefpodoxime proxetil (Vantin)
|9.||Histamine (Histamine Dihydrochloride)
|1.||Drug Therapy (Chemotherapy)